1. Home
  2. SPRC vs TOVX Comparison

SPRC vs TOVX Comparison

Compare SPRC & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • TOVX
  • Stock Information
  • Founded
  • SPRC 2004
  • TOVX 2001
  • Country
  • SPRC Israel
  • TOVX United States
  • Employees
  • SPRC N/A
  • TOVX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • TOVX Health Care
  • Exchange
  • SPRC Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • SPRC 3.4M
  • TOVX 3.8M
  • IPO Year
  • SPRC N/A
  • TOVX 2006
  • Fundamental
  • Price
  • SPRC $7.70
  • TOVX $0.50
  • Analyst Decision
  • SPRC
  • TOVX Hold
  • Analyst Count
  • SPRC 0
  • TOVX 1
  • Target Price
  • SPRC N/A
  • TOVX N/A
  • AVG Volume (30 Days)
  • SPRC 20.1K
  • TOVX 172.8K
  • Earning Date
  • SPRC 02-15-2025
  • TOVX 08-12-2025
  • Dividend Yield
  • SPRC N/A
  • TOVX N/A
  • EPS Growth
  • SPRC N/A
  • TOVX N/A
  • EPS
  • SPRC N/A
  • TOVX N/A
  • Revenue
  • SPRC $1,306,000.00
  • TOVX N/A
  • Revenue This Year
  • SPRC N/A
  • TOVX N/A
  • Revenue Next Year
  • SPRC N/A
  • TOVX N/A
  • P/E Ratio
  • SPRC N/A
  • TOVX N/A
  • Revenue Growth
  • SPRC N/A
  • TOVX N/A
  • 52 Week Low
  • SPRC $4.14
  • TOVX $0.40
  • 52 Week High
  • SPRC $37.59
  • TOVX $7.37
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 67.65
  • TOVX 51.01
  • Support Level
  • SPRC $6.25
  • TOVX $0.42
  • Resistance Level
  • SPRC $7.17
  • TOVX $0.48
  • Average True Range (ATR)
  • SPRC 0.59
  • TOVX 0.03
  • MACD
  • SPRC 0.10
  • TOVX 0.02
  • Stochastic Oscillator
  • SPRC 88.94
  • TOVX 82.80

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: